Concise review: Combining human leukocyte antigen G and mesenchymal stem cells for immunosuppressant biotherapy

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Stem Cells

• Publication date

  2013-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/stem.1494PMID 23922260
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine

  2013cited by this paper
• Mesenchymal stem cell: keystone of the hematopoietic stem cell niche and a stepping-stone for regenerative medicine.

  2013cited by this paper
• Regulation and function of immunosuppressive molecule human leukocyte antigen G5 in human bone tissue

  2013cited by this paper
• Clinical-Grade Mesenchymal Stromal Cells Produced Under Various Good Manufacturing Practice Processes Differ in Their Immunomodulatory Properties: Standardization of Immune Quality Controls

  2013cited by this paper
• Transplanted bone marrow mononuclear cells and MSCs impart clinical benefit to children with osteogenesis imperfecta through different mechanisms.

  2012cited by this paper
• Multipotent mesenchymal stromal cells and the innate immune system

  2012cited by this paper
• Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial.

  2012cited by this paper
• Enhancement of the immunosuppressive effect of human adipose tissue-derived mesenchymal stromal cells through HLA-G1 expression.

  2012cited by this paper
• Advances in graft-versus-host disease biology and therapy

  2012cited by this paper
• Mechanisms of rejection: current perspectives.

  2012cited by this paper
• Concise Review: Mesenchymal Stem Cells and Translational Medicine: Emerging Issues

  2012cited by this paper
• Bone regeneration with mesenchymal stem cells.

  2012cited by this paper
• Neoplastic B-cell growth is impaired by HLA-G/ILT2 interaction

  2012cited by this paper
• Mesenchymal stromal cell therapy for steroid-refractory acute and chronic graft versus host disease: a phase 1 study

  2012cited by this paper
• Current Status of Mesenchymal Stem Cell Therapy and Bone Marrow Transplantation in IBD

  2012cited by this paper
• Immunosuppressive properties of mesenchymal stem cells: advances and applications.

  2012cited by this paper
• Immunosuppressive therapy after kidney transplantation: current and new strategies.

  2011cited by this paper
• Multipotent Mesenchymal Stromal Cells for the Prophylaxis of Acute Graft-versus-Host Disease—A Phase II Study

  2011cited by this paper
• Clinical Application of Mesenchymal Stem Cells in the Treatment and Prevention of Graft-versus-Host Disease

  2011cited by this paper
• A simple method for identifying bone marrow mesenchymal stromal cells with a high immunosuppressive potential.

  2011cited by this paper
• Emerging immunosuppressive drugs in kidney transplantation.

  2011cited by this paper
• Mesenchymal stem cells and bone regeneration: current status.

  2011cited by this paper
• Human mesenchymal stem cells derived from induced pluripotent stem cells down-regulate NK-cell cytolytic machinery.

  2011cited by this paper
• Fifth Annual Stem Cell Summit.

  2010cited by this paper
• Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway.

  2010cited by this paper
• Mesenchymal stromal cells for graft-versus-host disease : basic aspects and clinical outcomes.

  2010cited by this paper
• Immunological regulation of trophoblast invasion.

  2010cited by this paper
• Advancement of mesenchymal stem cell therapy in solid organ transplantation (MISOT).

  2010cited by this paper
• Human mesenchymal stem cells modulate cellular immune response to islet antigen glutamic acid decarboxylase in type 1 diabetes.

  2010cited by this paper
• Repair of tissues by adult stem/progenitor cells (MSCs): controversies, myths, and changing paradigms.

  2009cited by this paper
• Mesenchymal stem cell homing: the devil is in the details.

  2009cited by this paper
• HLA-G is a Crucial Immunosuppressive Molecule Secreted by Adult Human Mesenchymal Stem Cells

  2009cited by this paper
• Cell therapy with autologous bone marrow mononuclear stem cells is associated with superior cardiac recovery compared with use of nonmodified mesenchymal stem cells in a canine model of chronic myocardial infarction.

  2009cited by this paper
• Adult stem cells: a clinical update.

  2009cited by this paper
• T cell suppression by naturally occurring HLA‐G‐expressing regulatory CD4+ T cells is IL‐10‐dependent and reversible

  2009cited by this paper
• Brief Report—Human Embryonic Stem Cell‐Derived Mesenchymal Progenitors Possess Strong Immunosuppressive Effects Toward Natural Killer Cells as Well as T Lymphocytes

  2009cited by this paper
• The CD34-like protein PODXL and alpha6-integrin (CD49f) identify early progenitor MSCs with increased clonogenicity and migration to infarcted heart in mice.

  2009cited by this paper
• Non-classical transcriptional regulation of HLA-G: an update

  2009cited by this paper
• Mesenchymal Stromal Cells: Current Understanding and Clinical Status

  2009cited by this paper
• Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6.

  2009cited by this paper
• In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells

  2008cited by this paper
• Human Leukocyte Antigen‐G5 Secretion by Human Mesenchymal Stem Cells Is Required to Suppress T Lymphocyte and Natural Killer Function and to Induce CD4+CD25highFOXP3+ Regulatory T Cells

  2008cited by this paper
• Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.

  2008cited by this paper
• Toll‐Like Receptors 3 and 4 Are Expressed by Human Bone Marrow‐Derived Mesenchymal Stem Cells and Can Inhibit Their T‐Cell Modulatory Activity by Impairing Notch Signaling

  2008cited by this paper
• Beyond the increasing complexity of the immunomodulatory HLA-G molecule.

  2008cited by this paper
• Heterogeneity of mesenchymal stromal cell preparations.

  2008cited by this paper
• Leukemia inhibitory factor: Role in human mesenchymal stem cells mediated immunosuppression.

  2008cited by this paper
• Early Detection of Decreased Soluble HLA‐G Levels in the Maternal Circulation Predicts the Occurrence of Preeclampsia and Intrauterine Growth Retardation During Further Course of Pregnancy

  2007cited by this paper
• CD3+CD4low and CD3+CD8low are induced by HLA-G: novel human peripheral blood suppressor T-cell subsets involved in transplant acceptance.

  2007cited by this paper
• Immunosuppressive Effects of Mesenchymal Stem Cells: Involvement of HLA-G

  2007cited by this paper
• Soluble HLA-G and HLA-G1 expressing antigen-presenting cells inhibit T-cell alloproliferation through ILT-2/ILT-4/FasL-mediated pathways.

  2007cited by this paper
• Mesenchymal Stem Cells Inhibit the Differentiation of Dendritic Cells Through an Interleukin‐6‐Dependent Mechanism

  2007cited by this paper
• Age‐ and Dose‐Related Effects on MSC Engraftment Levels and Anatomical Distribution in the Central Nervous Systems of Nonhuman Primates: Identification of Novel MSC Subpopulations That Respond to Guidance Cues in Brain

  2007cited by this paper
• Human multipotent mesenchymal stromal cells inhibit proliferation of PBMCs independently of IFNgammaR1 signaling and IDO expression.

  2007cited by this paper
• Derivation of Clinically Compliant MSCs from CD105+, CD24− Differentiated Human ESCs

  2007cited by this paper
• Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction.

  2007cited by this paper
• Trogocytosis‐based generation of suppressive NK cells

  2007cited by this paper
• Biochemical Heterogeneity of Mesenchymal Stem Cell Populations: Clues to their Therapeutic Efficacy

  2007cited by this paper
• Soluble human leukocyte antigen-G: a new strategy for monitoring acute and chronic rejections after heart transplantation.

  2007cited by this paper
• Implication of HLA-G in human embryo implantation.

  2007cited by this paper
• Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury

  2007cited by this paper
• Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.

  2006cited by this paper
• Soluble HLA-G in heart transplantation: their relationship to rejection episodes and immunosuppressive therapy.

  2006cited by this paper
• Human ILT2 receptor associates with murine MHC class I molecules in vivo and impairs T cell function

  2006cited by this paper
• OTI-010 Osiris Therapeutics/JCR Pharmaceuticals.

  2006cited by this paper
• Soluble HLA‐G Expression and Renal Graft Acceptance

  2006cited by this paper
• Comparative Analysis of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, or Adipose Tissue

  2006cited by this paper
• Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway

  2005cited by this paper
• Human mesenchymal stem cells modulate allogeneic immune cell responses.

  2005cited by this paper
• Mesenchymal stem cells induce apoptosis of activated T cells

  2005cited by this paper
• Indoleamine 2,3 dioxygenase and human leucocyte antigen‐G inhibit the T‐cell alloproliferative response through two independent pathways

  2005cited by this paper
• Mesenchymal stem cells: clinical applications and biological characterization.

  2004cited by this paper
• Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates.

  2003cited by this paper
• Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli.

  2002cited by this paper
• Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies.

  2002cited by this paper
• Polycythemia vera: myths, mechanisms, and management.

  2002cited by this paper
• Soluble HLA-G influences the release of cytokines from allogeneic peripheral blood mononuclear cells in culture.

  2001cited by this paper
• Human marrow stromal precursors are α1 integrin subunit‐positive

  2000cited by this paper
• Implication of HLA-G molecule in heart-graft acceptance.

  2000cited by this paper
• HLA‐G has a concentration‐dependent effect on the generation of an allo‐CTL response

  2000cited by this paper
• Cutting Edge: Soluble HLA-G1 Triggers CD95/CD95 Ligand-Mediated Apoptosis in Activated CD8+ Cells by Interacting with CD81

  2000cited by this paper
• Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta

  1999cited by this paper
• The immunotolerance role of HLA-G.

  1999cited by this paper
• Role of HLA-G in maternal-fetal immune tolerance.

  1999cited by this paper
• Multilineage potential of adult human mesenchymal stem cells.

  1999cited by this paper
• Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues

  1997cited by this paper
• [Alternative transcripts of the MHC of the non-classical class I HLA-G gene in the in trophoblast during the first pregnancy trimester and in the placenta at term].

  1995cited by this paper
• A class I antigen, HLA-G, expressed in human trophoblasts.

  1990cited by this paper

• Effect of Constant Inflammation on In Vitro Expanded Adipose-derived Mesenchymal Stromal Cells

  2025cites this paper
• UTILIZATION OF STEM CELL THERAPY AS A NEW APPROACH TO OVERCOME REPRODUCTIVE DISEASES IN WOMEN

  2024cites this paper
• Therapeutic Potential in Wound Healing of Allogeneic Use of Equine Umbilical Cord Mesenchymal Stem Cells

  2024cites this paper
• Alleviative Effects of Adipose Tissue-derived Stem Cells and α-NETA on Metabolic, Biochemical, and Endocrine Parameters in a Letrozole-induced Rat Model of PCOS.

  2023cites this paper
• NLRP3 inflammasome inhibition of OP9 cells enhance therapy for inflammatory bowel disease

  2023cites this paper
• Exploring the future potential of mesenchymal stem/stromal cells and their derivatives to support assisted reproductive technology for female infertility applications

  2023cites this paper
• Therapeutic Potential of Mesenchymal Stem Cells in PCOS.

  2023cites this paper
• Therapeutic restoration of female reproductive and endocrine dysfunction using stem cells.

  2023cites this paper
• Gestione delle bioterapie ad uso dei neurologi

  2023cites this paper
• Mechanisms behind therapeutic potentials of mesenchymal stem cell mitochondria transfer/delivery.

  2023cites this paper
• Effect of Intra-ovarian Injection of Mesenchymal Stem Cells or its Conditioned Media on Repeated OPU-IVEP Outcomes in Jersey Heifers and Its Relationship with Follicular Fluid Inflammatory Markers

  2023cites this paper
• Stem Cell Therapies for Chronic Liver Diseases: Progress and Challenges

  2022cites this paper
• Gestion des biothérapies à l’usage des neurologues

  2022cites this paper
• Cell therapy for the treatment of reproductive diseases and infertility: an overview from the mechanism to the clinic alongside diagnostic methods

  2022cites this paper
• Human Umbilical Cord-Based Therapeutics: Stem Cells and Blood Derivatives for Female Reproductive Medicine

  2022cites this paper
• The Therapeutic Potential of Human Umbilical Cord Derived Mesenchymal Stem Cells for the Treatment of Premature Ovarian Failure

  2022cites this paper
• Mesenchymal Stem Cells and MSCs-Derived Extracellular Vesicles in Infectious Diseases: From Basic Research to Clinical Practice

  2022cites this paper
• Stem cells for treatment of liver fibrosis/cirrhosis: clinical progress and therapeutic potential

  2022cites this paper
• An Overview on Biomaterials and Its Applications in Medical Science

  2021cites this paper
• Interplay between mesenchymal stromal cells and immune system: clinical applications in immune-related diseases

  2021cites this paper
• Wound Healing by Allogeneic Transplantation of Specific Subpopulation From Human Umbilical Cord Mesenchymal Stem Cells

  2021cites this paper
• HLA-G Neo-Expression on Tumors

  2020cites this paper
• Mesenchymal Stem Cells as a Bio Organ for Treatment of Female Infertility

  2020cites this paper
• Endometrial and Menstrual Blood Mesenchymal Stem/Stromal Cells: Biological Properties and Clinical Application

  2020cites this paper
• Biological functions of mesenchymal stem cells and clinical implications

  2019cites this paper
• Mesenchymal stem/stromal cell function in modulating cell death

  2019cites this paper
• Human Hepatocytes and Differentiated Adult-Derived Human Liver Stem/Progenitor Cells Display In Vitro Immunosuppressive Properties Mediated, at Least in Part, through the Nonclassical HLA Class I Molecule HLA-G

  2019cites this paper
• Using Mesenchymal Stem Cells to Treat Female Infertility: An Update on Female Reproductive Diseases

  2019cites this paper
• Studio dell'effetto immunomodulatorio in vitro di NGAL su PBMC di pazienti in trattamento emodialitico e iperimmuni

  2018cites this paper
• Historical Perspectives and Advances in Mesenchymal Stem Cell Research for the Treatment of Liver Diseases.

  2018cites this paper
• Microenvironnements pour l’analyse biologique et l’ingéniérie des tissus

  2018cites this paper
• Evaluation of HLA-G Expression in Multipotent Mesenchymal Stromal Cells Derived from Vitrified Wharton’s Jelly Tissue

  2018influential citation
• Mesenchymal Stem Cells Attenuate Radiation-Induced Brain Injury by Inhibiting Microglia Pyroptosis

  2017cites this paper
• Mesenchymal stem cells upregulate Treg cells via sHLA‐G in SLE patients

  2017cites this paper
• Biotherapy in Inflammatory Diseases of the CNS: Current Knowledge and Applications

  2017cites this paper
• Adipose‐derived mesenchymal stem cells modulate the immune response in chronic experimental autoimmune encephalomyelitis model

  2016cites this paper
• Interaction of EHV1 with equine dendritic cells and mesenchymal stem cells

  2016cites this paper
• Recent advances of biomaterials in biotherapy

  2016cites this paper
• The prognostic impact of soluble and vesicular HLA-G and its relationship to circulating tumor cells in neoadjuvant treated breast cancer patients.

  2016cites this paper
• International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials.

  2016cites this paper
• The Immunomodulatory Potential of Mesenchymal Stromal Cells: A Story of a Regulatory Network

  2016cites this paper
• Mesenchymal Stem Cells Derived from Human Bone Marrow and Adipose Tissue Maintain Their Immunosuppressive Properties After Chondrogenic Differentiation: Role of HLA-G

  2016influential citation
• Mesenchymal stromal cells for the treatment of autoimmune diseases

  2016cites this paper
• Tissue-specific Differentiation Potency of Mesenchymal Stromal Cells from Perinatal Tissues

  2016cites this paper
• Rationale for Determining the Functional Potency of Mesenchymal Stem Cells in Preventing Regulated Cell Death for Therapeutic Use

  2016cites this paper
• Endocytosis of indium-tin-oxide nanoparticles by macrophages provokes pyroptosis requiring NLRP3-ASC-Caspase1 axis that can be prevented by mesenchymal stem cells

  2016cites this paper
• Added effects of dexamethasone and mesenchymal stem cells on early Natural Killer cell activation.

  2016cites this paper
• Multidimensional Genome-wide Analyses Show Accurate FVIII Integration by ZFN in Primary Human Cells

  2015cites this paper
• Impact of immune response on the use of iPSCs in disease modeling.

  2015cites this paper
• Biomimetic chimeric peptide-tethered hydrogels for human mesenchymal stem cell delivery.

  2015cites this paper
• Pharmacokinetics and In Vivo Fate of Intra-Articularly Transplanted Human Bone Marrow-Derived Clonal Mesenchymal Stem Cells

  2015cites this paper
• Human Adipose‐Derived Mesenchymal Stem Cells Modulate Experimental Autoimmune Arthritis by Modifying Early Adaptive T Cell Responses

  2015cites this paper
• HLA-G: An Immune Checkpoint Molecule.

  2015cites this paper
• Suppression of human macrophage-mediated cytotoxicity by transgenic swine endothelial cell expression of HLA-G.

  2015cites this paper
• HLA-G Polymorphism (rs16375) and Acute Rejection in Liver Transplant Recipients

  2014cites this paper
• Osteodifferentiated Mesenchymal Stem Cells from Bone Marrow and Adipose Tissue Express HLA-G and Display Immunomodulatory Properties in HLA-Mismatched Settings: Implications in Bone Repair Therapy

  2014cites this paper
• Evaluation of gene delivery strategies to efficiently overexpress functional HLA-G on human bone marrow stromal cells

  2014cites this paper
• HLA-G as a Tolerogenic Molecule in Transplantation and Pregnancy

  2014cites this paper
• The Dual Role of HLA-G in Cancer

  2014cites this paper
• Clinical-Grade Mesenchymal Stromal Cells Produced Under Various Good Manufacturing Practice Processes Differ in Their Immunomodulatory Properties: Standardization of Immune Quality Controls

  2013cites this paper
• Immunosupressive Properties of HLA-G Molecules Produced by Mesenchymal Stromal Cells

  2013cites this paper